DrugRepV_1311 | Mupirocin | Dermatologicals and Respiratory System | Impetigo | Skin lesions (Staphylococci infections) | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (45.04 %) | Approved, Investigational, Vet approved | 27476412 |
DrugRepV_1332 | Mometasone Furoate | Dermatologicals and Respiratory System | Asthma | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (44.31 %) | Approved, Vet approved | 27476412 |
DrugRepV_1464 | Diphenhydramine Hydrochloride | Dermatologicals and Respiratory System | Vertigo/Meniere disease, nausea and vomiting, motion sickness and insect bite | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (42.965 %) | Approved | 27476412 |
DrugRepV_2071 | Diphenhydramine | Dermatologicals and Respiratory System | Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite | Ebola virus | HIV/EBOV | NA | Luciferase reporter assay | Decrease (50 %) | Approved | 29981374 |
DrugRepV_2073 | Diphenhydramine | Dermatologicals and Respiratory System | Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite | Marburg virus | HIV/MARV | NA | Luciferase reporter assay | Decrease (50 %) | Approved | 29981374 |
DrugRepV_2103 | Diphenhydramine | Dermatologicals and Respiratory System | Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite | Ebola virus | EBOV/kikwit | NA | Immunoblot assay | Decrease (50 %) | Approved | 29981374 |
DrugRepV_2105 | Diphenhydramine | Dermatologicals and Respiratory System | Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite | Ebola virus | EBOV/kikwit | NA | Immunoblot assay | Decrease (50 %) | Approved | 29981374 |
DrugRepV_2213 | Diphenhydramine Hydrochloride | Dermatologicals and Respiratory System | Vertigo/Meniere disease, nausea and vomiting, motion sickness and insect bite | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (7.67086 %) | Approved | 27742486 |
DrugRepV_2466 | Mometasone Furoate | Dermatologicals and Respiratory System | Asthma | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (0.77748045 %) | Approved, Vet approved | 27742486 |
DrugRepV_2671 | Tripelennamine Hydrochloride | Dermatologicals and Respiratory System | Gastrointestinal irritation | Asthma | HAY fever | Urticaria |Rhinitis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-2.4469427 %) | Approved | 27742486 |